Actively Recruiting
Studying Lung Immune Response and Airway Bacteria After Exposure to Tuberculosis in Adults Aged 18 to 65
Led by University of Oxford · Updated on 2025-01-22
50
Participants Needed
3
Research Sites
104 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are investigating the early immune response in the lungs and the respiratory microbiome after recent exposure to Mycobacterium tuberculosis M.tb, the bacteria that causes tuberculosis TB. This study aims to understand how variations in the bodys initial immune defense and the community of bacteria in the airways affect whether someone develops TB. The findings could help develop better vaccines and treatments for TB, a leading cause of infectious disease deaths worldwide. The study involves three groups of adult volunteers aged 18 to 65 those recently exposed to TB with positive immune tests, those recently exposed with negative immune tests, and healthy adults without prior TB exposure. Researchers will collect sputum and blood samples at enrollment and after 84 days to analyze innate immune cells and the diversity of bacteria in the airways. This observational study does not involve any treatments but focuses on monitoring immune and microbiome changes over time. Participants will provide consent and allow access to their medical records and previous test results. They will undergo sample collection for immune cell and microbiome analysis at two time points. The main outcomes measured include changes in immune cells in blood and sputum, and differences in airway bacterial diversity between exposed and healthy individuals. The study will last at least 84 days with careful monitoring to understand the bodys early defense against TB after exposure.
CONDITIONS
Brief Title
Lung Innate Immunity and Microbiome After Tuberculosis Exposure
Research Team
T
Timothy Fredsgaard-Jones, MBBS
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here